Literature DB >> 32080801

The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration.

Xiaoduan Li1, Meiling Tang1, Qinyi Zhu1, Xinjing Wang2, Yingying Lin3, Xipeng Wang4,5.   

Abstract

PURPOSE: Epithelial ovarian cancer (EOC) is one of the most malignant cancers in the gynecologic system. Many patients are diagnosed at an advanced stage with disseminated intra-peritoneal metastases. EOC spreads via both direct extension and trans-coelomic spread. However, the interplay between human peritoneal mesothelial cells (HPMCs) and EOC cells is still ambiguous. We hypothesize that integrins (ITG) in HPMCs may play important roles in EOC metastasis.
METHODS: The expression of different integrin subtypes from HPMCs was assessed using Western blotting. The expression of integrin α5β1 (ITGA5B1) and its co-localization with asparaginyl endopeptidase (AEP) in HPMCs derived from EOC patients (EOC-HPMCs) were assessed using immunofluorescence. The role and mechanism of the exosomal ITGA5B1/AEP complex in HPMCs was assessed using both in vitro and in vivo assays. A retrospective study involving 234 cases was carried out to assess ITGA5B1 and AEP levels in circulating sera and ascites of EOC patients, as well as associations between ITGA5B1/AEP expression and overall survival.
RESULTS: We found that ITGA5B1was highly expressed and co-localized with AEP in EOC cells, and that the exosomal ITGA5B1/AEP complex secreted by EOC cells played an important role in the proliferation and migration of HPMCs. High levels of exosomal ITGA5B1/AEP were also found in circulating sera and ascites of EOC patients, and the expression of ITGA5B1/AEP in EOC tissues was found to be negatively associated with overall survival.
CONCLUSIONS: Our data indicate that EOCs may regulate the function of HPMCs through exosomal ITGA5B1/AEP, which may be crucial for peritoneal metastasis.

Entities:  

Keywords:  AEP; Epithelial ovarian cancer; HPMC; Integrin; Peritoneal metastasis

Mesh:

Substances:

Year:  2020        PMID: 32080801     DOI: 10.1007/s13402-019-00486-4

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  52 in total

1.  Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.

Authors:  Dalong Cao; Zihao Qi; Yangyang Pang; Haoran Li; Huyang Xie; Junlong Wu; Yongqiang Huang; Yao Zhu; Yijun Shen; Yiping Zhu; Bo Dai; Xin Hu; Dingwei Ye; Ziliang Wang
Journal:  Cancer Res       Date:  2019-02-26       Impact factor: 12.701

2.  Isolation, culture and characterization of human peritoneal mesothelial cells.

Authors:  E Stylianou; L A Jenner; M Davies; G A Coles; J D Williams
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

Review 3.  Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

Authors:  W Glenn McCluggage
Journal:  Pathology       Date:  2011-08       Impact factor: 5.306

4.  PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Authors:  Leslie Ann Caromile; Kristina Dortche; M Mamunur Rahman; Christina L Grant; Christopher Stoddard; Fernando A Ferrer; Linda H Shapiro
Journal:  Sci Signal       Date:  2017-03-14       Impact factor: 8.192

5.  Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.

Authors:  Raghavendra Vasudeva Murthy; Gunnar Arbman; Jingfang Gao; G David Roodman; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

6.  High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.

Authors:  Mads H Haugen; Kjetil Boye; Jahn Martin Nesland; Solveig J Pettersen; Eivind Valen Egeland; Tripti Tamhane; Klaudia Brix; Gunhild M Maelandsmo; Kjersti Flatmark
Journal:  Eur J Cancer       Date:  2014-11-11       Impact factor: 9.162

7.  Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.

Authors:  Khayal Gasimli; Elena Ioana Braicu; Rolf Richter; Radoslav Chekerov; Jalid Sehouli
Journal:  Ann Surg Oncol       Date:  2015-02-12       Impact factor: 5.344

8.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

9.  Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells.

Authors:  Fernando E Sepulveda; Sophia Maschalidi; Renaud Colisson; Lea Heslop; Cristina Ghirelli; Emna Sakka; Ana-Maria Lennon-Duménil; Sebastian Amigorena; Lucien Cabanie; Bénédicte Manoury
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

10.  Extracellular Hsp90 and TGFβ regulate adhesion, migration and anchorage independent growth in a paired colon cancer cell line model.

Authors:  Jo-Anne de la Mare; Tamarin Jurgens; Adrienne L Edkins
Journal:  BMC Cancer       Date:  2017-03-16       Impact factor: 4.430

View more
  12 in total

1.  Oral Cancer Cells Release Vesicles that Cause Pain.

Authors:  Zinaida A Dubeykovskaya; Nguyen Huu Tu; Paulina D Ramírez Garcia; Brian L Schmidt; Donna G Albertson
Journal:  Adv Biol (Weinh)       Date:  2022-07-08

2.  Active legumain promotes invasion and migration of neuroblastoma by regulating epithelial-mesenchymal transition.

Authors:  Min Zhang; Jianhua Zhu; Wei Wang; Zhiteng Jiang
Journal:  Open Life Sci       Date:  2022-06-21       Impact factor: 1.311

3.  miR-27b Suppresses Tongue Squamous Cell Carcinoma Epithelial-Mesenchymal Transition by Targeting ITGA5.

Authors:  Tao Li; Qian Wu; Duanqin Liu; Xuxia Wang
Journal:  Onco Targets Ther       Date:  2020-11-17       Impact factor: 4.147

Review 4.  Targeting Integrins for Cancer Therapy - Disappointments and Opportunities.

Authors:  Cecilia Bergonzini; Kim Kroese; Annelien J M Zweemer; Erik H J Danen
Journal:  Front Cell Dev Biol       Date:  2022-03-09

Review 5.  The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review.

Authors:  Wenrui Zhang; Yingying Lin
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

6.  The Exocrine Differentiation and Proliferation Factor (EXDPF) Gene Promotes Ovarian Cancer Tumorigenesis by Up-Regulating DNA Replication Pathway.

Authors:  Yangjiong Xiao; Yunxin Lai; Yang Yu; Pengcheng Jiang; Yuhong Li; Chao Wang; Rong Zhang
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

7.  Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer.

Authors:  Desirée Martínez-Martínez; María-Val Toledo Lobo; Pablo Baquero; Santiago Ropero; Javier C Angulo; Antonio Chiloeches; Marina Lasa
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639

8.  Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene.

Authors:  Ada-Sophia Clees; Verena Stolp; Björn Häupl; Dominik C Fuhrmann; Frank Wempe; Marcel Seibert; Sarah Weber; Antje Banning; Ritva Tikkanen; Richard Williams; Bernhard Brüne; Hubert Serve; Frank Schnütgen; Ivana von Metzler; Nina Kurrle
Journal:  Cells       Date:  2022-01-15       Impact factor: 6.600

9.  Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.

Authors:  Lingling Gao; Xin Nie; Rui Gou; Yuexin Hu; Hui Dong; Xiao Li; Bei Lin
Journal:  J Cell Mol Med       Date:  2021-11-01       Impact factor: 5.310

Review 10.  Lysosomal peptidases-intriguing roles in cancer progression and neurodegeneration.

Authors:  Janko Kos; Ana Mitrović; Milica Perišić Nanut; Anja Pišlar
Journal:  FEBS Open Bio       Date:  2022-02-03       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.